Negative Pressure Wound Therapy Market by Product (Conventional, Single-use NPWT, Consumables, Accessories), Wound Type (Burns, Surgical, Traumatic, Diabetic Foot, Pressure, Venous Leg Ulcers), End User (Hospitals, Homecare) - Global Forecast to 2030
The global negative pressure wound therapy market is projected to reach USD 3.84 billion by 2030 from USD 2.76 billion in 2025, at a CAGR of 6.9% during the forecast period.
Scope of the Report
Years Considered for the Study
2024-2030
Base Year
2024
Forecast Period
2024-2030
Units Considered
Value (USD billion)
Segments
Product type, Wound type, and End User
Regions covered
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
This is due to the increasing rise of diabetic patients, rising cases of traumatic injuries and burn injuries, and the growing geriatric population, which drives market growth. Additionally, rising usage of simplified single-use devices is expected to impact market growth.
"The hospitals segment of the negative pressure wound therapy market, by end user, is expected to hold the largest position during the forecast period."
Based on the end user, the negative pressure wound therapy market is divided into home care settings, hospitals, and other end users. Among these, hospitals hold the largest market share in 2024. The need for advanced wound care products in hospitals has been further stimulated by the rising incidence of diabetic foot ulcers and post-operative wounds. Hospital visits for wound care have also increased as a result of the growing geriatric population with chronic illnesses, including diabetes and vascular diseases. Hospitals can treat wounds quickly and effectively due to established protocols, knowledgeable medical staff, and a wide range of traditional wound care materials. As a result of the increased focus on improving wound care practices and patient recovery rates, this market segment continues to hold its dominant position.
"The burns and surgical & open wounds accounted for the largest market share in the negative pressure wound therapy market."
The negative pressure wound therapy market is segmented into burns and surgical & open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and traumatic wounds. The burns and surgical & open wounds segment accounted for the largest share in the negative pressure wound therapy market in 2024. Burns and surgical & open wounds are leading segments in the negative pressure wound therapy market due to their rising occurrence and complexity, which require advanced wound management solutions. NPWT devices are particularly effective in managing these types of wounds, as they promote quicker healing, reduce infection risk, and improve tissue regeneration. Surgical wounds involving large incisions or at risk of dehiscence benefit significantly from maintaining a clean, moist wound environment and reducing edema.
"Asia Pacific is the fastest-growing region of the negative pressure wound therapy market by region."
The global negative pressure wound therapy market is segmented into five segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific negative pressure wound therapy market is growing due to the geriatric population, rising healthcare costs, and a growing incidence of chronic wounds. Asia Pacific offers high growth opportunities for players in the market. This segment is slated to register the highest CAGR during the forecast period.
As the number of surgeries, road accidents, and burn cases increases, there is an increasing need for effective wound care therapies. The growing incidence of diabetes has led to a rise in diabetic foot ulcers, highlighting the significance of proper wound care. The expansion of the healthcare system, e-commerce, and pharmacies has made the negative pressure wound therapy product accessible than ever. As awareness of wound care improves and healthcare services advance, the demand for negative pressure wound therapy solutions in the Mexico region is expected to see continued growth.
A breakdown of the primary participants referred to for this report is provided below:
By Company Type: Tier 1: 38%, Tier 2: 29%, and Tier 3: 33%
By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
By Region: North America: 50%, Europe: 20%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 3%
Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the negative pressure wound therapy market are Solventum (US), Smith+Nephew (UK), Cardinal Health (US), Molnlycke AB (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Avery Dennison Corporation (US), BenQ Materials Corporation (Taiwan), Double Medical Technology Inc. (China), Advanced Oxygen Therapy Inc. (US), and Carilex Medical (Taiwan).
Research Coverage
This report studies the negative pressure wound therapy market based on product type, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights on the following pointers:
Analysis of key drivers (booming geriatric population, increasing cases of traumatic injuries, growing prevalence of chronic diseases
rising incidence of burn injuries
and favorable government and industry initiatives and reimbursements), restraints (high cost of negative pressure wound devices,
and risks associated with use of negative pressure wound therapy products), opportunities (high growth opportunities in emerging economies
and growing usage of simplified single-use devices), challenges (availability of alternative therapies, and Limited awareness among healthcare providers)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the negative pressure wound therapy market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the negative pressure wound therapy market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the negative pressure wound therapy market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Key data from primary sources
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews